All 32 PJP (INVESCO PHARMACEUTICALS ETF) Holdings
There are 32 PJP holdings. Top 10 companies weight: 47.61%.
Total Market Cap: $3.16T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (32 stocks) | +15.73% | 27.23 | 17.86 | 0.35 | +15.91% | +19.32% | 0.42 | ||||||||||
1 | LLY | Eli Lilly And Co | 5.24% | $1,065.12 | $970B | Drug Manufacturers - General | Healthcare | +29.14% | 45.43 | 29.85 | 0.18 | N/A | N/A | 71 | +14.08% | $1.22K | +40.67% | 0.71 |
2 | LQDA | Liquidia Corp Ordinary Shares | 5.08% | $55.11 | $5.48B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 257.84 | 28.33 | N/A | N/A | N/A | 72 | +18.16% | $65 | +79.11% | 1.13 |
3 | MRK | Merck & Co Inc | 4.95% | $115.70 | $297B | Drug Manufacturers - General | Healthcare | +4.39% | 27.45 | 22.78 | 5.59 | N/A | N/A | 69 | +12.13% | $130 | +12.86% | 0.32 |
4 | PFE | Pfizer Inc | 4.88% | $25.55 | $149B | Drug Manufacturers - General | Healthcare | -6.35% | 12.31 | 8.73 | 0.09 | N/A | N/A | 56 | +14.25% | $29 | -3.24% | 0.40 |
5 | JNJ | Johnson & Johnson | 4.79% | $222.89 | $557B | Drug Manufacturers - General | Healthcare | +11.59% | 20.68 | 19.49 | 3.01 | N/A | N/A | 68 | +13.45% | $253 | +9.09% | 0.01 |
6 | ABBV | Abbvie Inc | 4.78% | $215.41 | $381B | Drug Manufacturers - General | Healthcare | -19.65% | 122.69 | 14.95 | 0.59 | N/A | N/A | 75 | +17.40% | $253 | +18.31% | 0.32 |
7 | CORT | Corcept Therapeutics Inc | 4.69% | $71.20 | $6.96B | Biotechnology | Healthcare | -8.23% | 158.39 | 85.47 | 0.81 | N/A | N/A | N/A | N/A | N/A | +26.78% | N/A |
8 | GILD | Gilead Sciences Inc | 4.64% | $127.57 | $166B | Drug Manufacturers - General | Healthcare | +98.59% | 18.01 | 15.22 | 0.33 | N/A | N/A | N/A | N/A | N/A | +18.23% | N/A |
9 | AMGN | Amgen Inc | 4.49% | $328.26 | $181B | Drug Manufacturers - General | Healthcare | +3.49% | 23.21 | 14.79 | 0.75 | N/A | N/A | 60 | +7.30% | $352 | +10.27% | 0.48 |
10 | TVTX | Travere Therapeutics Inc Ordinary Shares | 4.07% | $42.96 | $4.41B | Biotechnology | Healthcare | -44.12% | N/A | 61.73 | N/A | N/A | N/A | 76 | +26.02% | $54 | +24.56% | 1.30 |
11 | ABT | Abbott Laboratories | 3.87% | $86.96 | $149B | Medical Devices | Healthcare | +14.67% | 25.62 | 16.03 | 6.83 | N/A | N/A | 72 | +34.88% | $117 | -2.63% | 0.21 |
12 | JAZZ | Jazz Pharmaceuticals Plc | 3.87% | $226.12 | $15B | Biotechnology | Healthcare | N/A | N/A | 12.69 | 0.99 | N/A | N/A | 78 | +11.98% | $253 | +5.45% | 0.73 |
13 | LGND | Ligand Pharmaceuticals Inc | 3.53% | $232.76 | $4.72B | Biotechnology | Healthcare | +26.59% | 30.19 | 25.77 | 1.53 | N/A | N/A | 80 | +19.26% | $278 | +15.54% | 1.02 |
14 | UTHR | United Therapeutics Corp | 3.46% | $540.05 | $24B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 19.28 | 19.88 | 2.05 | N/A | N/A | 71 | +23.18% | $665 | +25.24% | 0.45 |
15 | HRMY | Harmony Biosciences Holdings Inc Ordinary Shares | 3.03% | $30.91 | $1.78B | Biotechnology | Healthcare | N/A | 12.18 | 10.08 | N/A | N/A | N/A | 63 | +43.51% | $44 | -1.26% | 0.69 |
16 | ANIP | Ani Pharmaceuticals Inc | 3.01% | $74.65 | $1.71B | Drug Manufacturers - Specialty & Generic | Healthcare | +25.74% | 20.61 | 9.51 | 0.01 | N/A | N/A | 81 | +47.19% | $110 | +16.83% | 0.64 |
17 | VTRS | Viatris Inc | 2.87% | $15.69 | $19B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 6.41 | 0.14 | N/A | N/A | 61 | +15.11% | $18 | +4.66% | 0.80 |
18 | BIIB | Biogen Inc | 2.81% | $188.83 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.38 | 14.04 | 0.64 | N/A | N/A | 63 | +16.21% | $219 | -7.08% | 0.54 |
19 | INVA | Innoviva Inc | 2.75% | $21.35 | $1.63B | Biotechnology | Healthcare | +16.74% | 3.19 | 11.12 | 0.33 | N/A | N/A | 62 | +66.28% | $36 | +10.06% | 0.22 |
20 | BMY | Bristol-myers Squibb Co | 2.67% | $54.46 | $117B | Drug Manufacturers - General | Healthcare | +5.08% | 13.54 | 9.06 | 183.93 | N/A | N/A | 61 | +15.83% | $63 | +0.55% | 0.26 |
21 | OCUL | Ocular Therapeutix Inc | 2.63% | $8.31 | $1.87B | Biotechnology | Healthcare | -4.26% | N/A | N/A | N/A | N/A | N/A | 84 | +212.88% | $26 | -10.44% | 1.35 |
22 | SUPN | Supernus Pharmaceuticals Inc | 2.54% | $44.07 | $2.71B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 20.16 | 1.47 | N/A | N/A | 75 | +42.57% | $63 | +8.17% | 0.51 |
23 | AMRX | Amneal Pharmaceuticals Inc Ordinary Shares Class A | 2.47% | $12.65 | $4.04B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | 40.55 | 6.30 | N/A | N/A | N/A | 85 | +35.97% | $17 | +18.00% | 0.97 |
24 | REGN | Regeneron Pharmaceuticals Inc | 2.33% | $602.92 | $65B | Biotechnology | Healthcare | +20.31% | 14.98 | 13.39 | 83.17 | N/A | N/A | 72 | +38.21% | $833 | +3.75% | 0.64 |
25 | TARS | Tarsus Pharmaceuticals Inc Ordinary Shares | 2.31% | $57.41 | $2.58B | Biotechnology | Healthcare | N/A | N/A | 106.38 | N/A | N/A | N/A | 77 | +63.93% | $94 | +11.68% | 0.65 |
26 | COLL | Collegium Pharmaceutical Inc | 2.12% | $30.48 | $1.09B | Drug Manufacturers - Specialty & Generic | Healthcare | -5.45% | 36.96 | 4.28 | N/A | N/A | N/A | 79 | +78.25% | $54 | +6.28% | 0.54 |
27 | PRGO | Perrigo Co Plc | 2.10% | $10.46 | $1.54B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 5.08 | N/A | N/A | N/A | 65 | +57.74% | $17 | -22.80% | 0.76 |
28 | PBH | Prestige Consumer Healthcare Inc | 1.98% | $45.83 | $2.34B | Drug Manufacturers - Specialty & Generic | Healthcare | +8.18% | 12.35 | 10.24 | 1.46 | N/A | N/A | 67 | +45.76% | $67 | -1.87% | 0.45 |
29 | AMPH | Amphastar Pharmaceuticals Inc | 1.93% | $18.45 | $853M | Drug Manufacturers - Specialty & Generic | Healthcare | +101.37% | 11.10 | N/A | 2.77 | N/A | N/A | 60 | +26.45% | $23 | -0.23% | 0.80 |
30 | AGPXX | Invesco Shrt-trm Inv Gov&agcy Instl | 0.11% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
31 | n/a | Omniab | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
32 | n/a | Securities Lending Bnym | 0.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
PJP (INVESCO PHARMACEUTICALS ETF) Sector Allocation
HEALTHCARE
99.90%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%